Skip to content

The "Harmony" mechanism of the integration of the periaqueductal gray (PAG) functional network in migraine by opposing needling at Shaoyang acupoints

The "Harmony" mechanism of the integration of the periaqueductal gray (PAG) functional network in migraine by opposing needling at Shaoyang acupoints

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069456
Enrollment
Unknown
Registered
2023-03-16
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

Group A:opposing needling
Group B:affected side needling
Group C:Sham opposing needling
Healthy Group:None

Sponsors

The Second Affiliated Hospital of Yunnan University of Chinese Medicine/Yunnan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Migraine (1) Right-handed, female, high school or above education, aged 18-45 years old; (2) Patient meets the diagnostic criteria of migraine without aura in the International Classification of Headache Disorders ICHD-3 designated by the International Headache Society (IHS) in 2018; (3) In the past 3 months, the headache attack was >= 2 times per month, and the headache days were < 15 days per month; (4) Moderate headache attacks (VAS score of 3-7) in the last 2 weeks (baseline period); (5) History of migraine for more than 1 year and no history of long-term dysmenorrhea; (6) Not taking painkillers within 1 month; (7) Not having received acupuncture treatment within 1 month; (8) Those who voluntarily participate in this study and sign the written informed consent; (9) No metallic implants in the body and no fMRI contraindications; (10) Not participating in any other trial during the study period; Note: Patients who meet the above 10 items at the same time may be included in this study. 2. Healthy subjects (1) Right-handed, female, high school or above education, aged 18-45 years old; (2) No history of long-term dysmenorrhea, any neurological or psychiatric diseases, or family genetic history; (3) No physical abnormalities (e.g. cold, fever, etc.) during the trial; (4) Not drugs or alcohol use for at least 2 days before enrollment, and no use of any stimulant medication for at least 1 month. (Only if the above 4 criteria are met at the same time can be included)

Exclusion criteria

Exclusion criteria: 1. Migraine Patients matching any of the following criteria will be excluded: (1) Patients with bilateral or alternating unilateral migraine, or with other chronic pain (e.g., dysmenorrhoea, chronic low back pain, etc.); (2) Patients with other types of headaches or headaches of unknown diagnosis; (3) Patients with severe organ or body diseases; (4) Those with severe anxiety, depression, insomnia and other psychiatric disorders; (5) Pregnant and lactating women, or those who have the need to have children within the last year; (6) Patients with definite organic lesions of the brain or significant asymmetry between the right and left side of the skull; (7) Patients with conditions contraindicating MRI (e.g., metallic foreign bodies, vascular stents, pacemakers, dentures, claustrophobia, etc.); (8) Patients who are currently taking analgesics and psychotropic drug dependence; (9) People with special needs such as transgender, homosexual, abnormal sexual orientation, special fetishes, alcohol addiction, etc.; (10) Have participated in a similar study within the last 3 months. 2. Healthy subjects (1) Accompanied by serious diseases of the heart, brain, liver, kidney and other important organs; (2) With mental or physical disabilities; (3) Suspected or true history of alcohol or drug abuse (4) With conditions contraindicating MRI (e.g. metallic foreign bodies, vascular stents, pacemakers, dentures, claustrophobia, etc.); (5) Women are pregnant and lactating. (Any one item is excluded)

Design outcomes

Primary

MeasureTime frame
Multimodal image data;Visual analogue scale score of headache intensity;

Secondary

MeasureTime frame
Days of headache attacks;Number of headache attacks;

Countries

China

Contacts

Public ContactTaipin Guo

Yunnan University of Chinese Medicine

gtphncs@126.com+86 18487272658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026